Syfovre: payments to doctors
Payments that named Syfovre as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.1M
- Providers
- 5,544
- Transactions
- 19,061
- Average per transaction
- $319
The per-transaction average — $319 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,544 providers the average total is $1,096, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | $6,073,524 | 100.0% |